Brief: Aditxt Subsidiary Adimune Signs Clinical Trial Agreement With Top Research Institution To Study Stiff Person Syndrome
05/05/2023 12:25
Aditxt Inc ADTX.O :
* ADITXT SUBSIDIARY ADIMUNE SIGNS CLINICAL TRIAL AGREEMENT
WITH
TOP RESEARCH INSTITUTION TO STUDY STIFF PERSON SYNDROME
* ADITXT INC - CLINICAL TRIAL AT MAYO CLINIC IS PLANNED WITH
ENROLLMENT OF APPROXIMATELY 10-15 PATIENTS
Source text for Eikon: ID:nBwPHnzsa
Further company coverage: ADTX.O
Recent news on Aditxt
See all newsBrief: Ignite Proteomics Announces 10,000-Patient Oncology Registry For Therapy Selection
Brief: Aditxt Appoints Jeffrey M. Busch As Interim CEO; Founder And Former CEO Of $1B NYSE Enterprise Which Delivered ~8.5% Dividends To Shareholders
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 03:28 AM